The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Open accessAbstract
BACKGROUND: Few investigations have evaluated the incremental usefulness of multiple biomarkers from distinct biologic pathways for predicting the risk of cardiovascular events. METHODS: We measured 10 biomarkers in 3209 participants attending a routine examination cycle of the Framingham Heart Study: the levels of C-reactive protein, B-type natriuretic peptide, N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen-activator inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio. RESULTS: During follow-up (median, 7.4 years), 207 participants died and 169 had a first major cardiovascular event. In Cox proportional-hazards models adjusting for conventional risk factors, the following biomarkers most strongly predicted the risk of death (each biomarker is followed by the adjusted hazard ratio per 1 SD increment in the log values): B-type natriuretic peptide level (1.40), C-reactive protein level (1.39), the urinary albumin-to-creatinine ratio (1.22), homocysteine level (1.20), and renin level (1.17). The biomarkers that most strongly predicted major cardiovascular events were B-type natriuretic peptide level (adjusted hazard ratio, 1.25 per 1 SD increment in the log values) and the urinary albumin-to-creatinine ratio (1.20). Persons with "multimarker" scores (based on regression coefficients of significant biomarkers) in the highest quintile as compared with those with scores in the lowest two quintiles had elevated risks of death (adjusted hazard ratio, 4.08; P<0.001) and major cardiovascular events (adjusted hazard ratio, 1.84; P=0.02). However, the addition of multimarker scores to conventional risk factors resulted in only small increases in the ability to classify risk, as measured by the C statistic. CONCLUSIONS: For assessing risk in individual persons, the use of the 10 contemporary biomarkers that we studied adds only moderately to standard risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Self-citationPearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Self-citationRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationDanesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
Self-citation
Cited by
Brook, R. D., Rajagopalan, S., Pope, C. A., Brook, J. R., Bhatnagar, A., Diez-Roux, A. V., Holguin, F., Hong, Y., Luepker, R. V., Mittleman, M. A., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181dbece1 · Cited by 6,548
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
“This increase, however, is often very small in magnitude; for example, Wang et al. show that the addition of a biomarker score to a set of standard risk factors predicting CVD increases the model AUC only from 0.76 to 0.77 [ 12 ].”
BackgroundInfluentialSelf-citationMancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Systematic reviews: CRD's guidance for undertaking reviews in health care
Tacconelli, E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70065-7 · Cited by 3,245
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,112
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Self-citationAortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S. G., Benjamin, E. J., Boutouyrie, P., Cameron, J., Chen, C.-H., Cruickshank, J. K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.063 · Cited by 1,835
Self-citationRidker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Self-citationMancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
Self-citationHoule, D., Govindaraju, D. R., & Omholt, S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2897 · Cited by 1,279
Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
Gaziano, T. A., Bitton, A., Anand, S., Abrahams-Gessel, S., & Murphy, A. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2009.10.002 · Cited by 1,176
Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J. A., Damasceno, A., Delles, C., Gimenez-Roqueplo, A.-P., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 939
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Khan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Circulation · doi:10.1161/circulationaha.107.183885 · Cited by 757
Saunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., Hoogeveen, R. C., Liu, X., Astor, B. C., Mosley, T. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005264 · Cited by 755
Latini, R., Masson, S., Anand, I. S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655076 · Cited by 709
Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705
Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve
Cook, N. R. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.096529 · Cited by 691
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 623
Chow, S. L., Maisel, A. S., Anand, I., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000490 · Cited by 601
Self-citationStenvinkel, P., Carrero, J. J. A. A., Axelsson, J., Lindholm, B., Heimbu[Combining Diaeresis]rger, O., & Massy, Z. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03670807 · Cited by 561
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 551
Pham, B. T., Pradhan, B., Tien Bui, D., Prakash, I., & Dholakia, M. B. (2016) · Environmental Modelling & Software · doi:10.1016/j.envsoft.2016.07.005 · Cited by 546
McGill, H. C., McMahan, C. A., & Gidding, S. S. (2008) · Circulation · doi:10.1161/circulationaha.107.717033 · Cited by 536
Interpreting Incremental Value of Markers Added to Risk Prediction Models
Pencina, M. J., D'Agostino, R. B., Pencina, K. M., Janssens, A. C. J. W., & Greenland, P. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws207 · Cited by 506
Self-citationPrognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482
“This premise is further supported by their relatively low correlation, indicating that they provide nonoverlapping information.60 Uncorrelated biomarkers are particularly attractive candidates for combining into “multimarker” panels.61 Several studies have examined the performance of multimarker panels in primary prev…”
BackgroundMethodResultInfluentialThe Limitations of Risk Factors as Prognostic Tools
Ware, J. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068249 · Cited by 466
Gersh, B. J., Sliwa, K., Mayosi, B. M., & Yusuf, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq030 · Cited by 465
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436
Lin, M., Song, P., Zhou, G., Zuo, X., Aldalbahi, A., Lou, X., Shi, J., & Fan, C. (2016) · Nature Protocols · doi:10.1038/nprot.2016.071 · Cited by 388
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386
Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 382
Vascular Aging: A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention
Nilsson, P. M., Boutouyrie, P., & Laurent, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129114 · Cited by 380
Anderson, T. J., Charbonneau, F., Title, L. M., Buithieu, J., Rose, M. S., Conradson, H., Hildebrand, K., Fung, M., Verma, S., & Lonn, E. M. (2011) · Circulation · doi:10.1161/circulationaha.110.953653 · Cited by 380
Di Angelantonio, E., Chowdhury, R., Sarwar, N., Ray, K. K., Gobin, R., Saleheen, D., Thompson, A., Gudnason, V., Sattar, N., & Danesh, J. (2009) · Circulation · doi:10.1161/circulationaha.109.884866 · Cited by 378
Gaziano, T. A., Young, C. R., Fitzmaurice, G., Atwood, S., & Gaziano, J. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60418-3 · Cited by 366
Blankenberg, S., Zeller, T., Saarela, O., Havulinna, A. S., Kee, F., Tunstall-Pedoe, H., Kuulasmaa, K., Yarnell, J., Schnabel, R. B., Wild, P. S., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901413 · Cited by 367
Deelen, J., Kettunen, J., Fischer, K., van der Spek, A., Trompet, S., Kastenmüller, G., Boyd, A., Zierer, J., van den Akker, E. B., Ala-Korpela, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11311-9 · Cited by 362
Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study
Kavousi, M., Elias-Smale, S., Rutten, J. H. W., Leening, M. J. G., Vliegenthart, R., Verwoert, G. C., Krestin, G. P., Oudkerk, M., de Maat, M. P. M., Leebeek, F. W. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00006 · Cited by 360
Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Self-citationThe search for new cardiovascular biomarkers
Gerszten, R. E., & Wang, T. J. (2008) · Nature · doi:10.1038/nature06802 · Cited by 358
Self-citationCao, J. J., Arnold, A. M., Manolio, T. A., Polak, J. F., Psaty, B. M., Hirsch, C. H., Kuller, L. H., & Cushman, M. (2007) · Circulation · doi:10.1161/circulationaha.106.645606 · Cited by 347
Gervais, L., & Delamarche, E. (2009) · Lab on a Chip · doi:10.1039/b906523g · Cited by 345
Fischer, K., Kettunen, J., Würtz, P., Haller, T., Havulinna, A. S., Kangas, A. J., Soininen, P., Esko, T., Tammesoo, M.-L., Mägi, R., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001606 · Cited by 344
de Ruijter, W., Westendorp, R. G. J., Assendelft, W. J. J., den Elzen, W. P. J., de Craen, A. J. M., le Cessie, S., & Gussekloo, J. (2009) · BMJ · doi:10.1136/bmj.a3083 · Cited by 339
Statistical methods for assessment of added usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Vasan, R. S. (2010) · cclm · doi:10.1515/cclm.2010.340 · Cited by 333
Self-citationMosley, J. D., Gupta, D. K., Tan, J., Yao, J., Wells, Q. S., Shaffer, C. M., Kundu, S., Robinson-Cohen, C., Psaty, B. M., Rich, S. S., et al. (2020) · JAMA · doi:10.1001/jama.2019.21782 · Cited by 332
Self-citationCardiovascular Disease Risk Assessment: Insights from Framingham
D’Agostino Sr., R. B., Pencina, M. J., Massaro, J. M., & Coady, S. (2013) · Global Heart · doi:10.1016/j.gheart.2013.01.001 · Cited by 329
Arterial thrombus formation in cardiovascular disease
Lippi, G., Franchini, M., & Targher, G. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.91 · Cited by 321
The Treatment of Hyperhomocysteinemia
Maron, B. A., & Loscalzo, J. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123308 · Cited by 313
Inflammation in Peripheral Artery Disease
Brevetti, G., Giugliano, G., Brevetti, L., & Hiatt, W. R. (2010) · Circulation · doi:10.1161/circulationaha.109.918417 · Cited by 313
Fang, M. C., Go, A. S., Chang, Y., Borowsky, L., Pomernacki, N. K., & Singer, D. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.065 · Cited by 312
Smith, J. G., Newton-Cheh, C., Almgren, P., Struck, J., Morgenthaler, N. G., Bergmann, A., Platonov, P. G., Hedblad, B., Engström, G., Wang, T. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.049 · Cited by 311
Self-citationMisuse of DeLong test to compare AUCs for nested models
Demler, O. V., Pencina, M. J., & D'Agostino, R. B. (2012) · Statistics in Medicine · doi:10.1002/sim.5328 · Cited by 306
Self-citationEstablished and Emerging Roles of Biomarkers in Heart Failure
Ibrahim, N. E., & Januzzi, J. L. (2018) · Circulation Research · doi:10.1161/circresaha.118.312706 · Cited by 306
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
Self-citationCheung, C. Y., Xu, D., Cheng, C.-Y., Sabanayagam, C., Tham, Y.-C., Yu, M., Rim, T. H., Chai, C. Y., Gopinath, B., Mitchell, P., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00626-4 · Cited by 302
Wong, N. D., Budoff, M. J., Ferdinand, K., Graham, I. M., Michos, E. D., Reddy, T., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100335 · Cited by 302
Marshall, J. C., & Reinhart, K. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02afc · Cited by 294
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Wang, T. J. (2011) · Circulation · doi:10.1161/circulationaha.109.912568 · Cited by 294
Self-citationNozaki, T., Sugiyama, S., Koga, H., Sugamura, K., Ohba, K., Matsuzawa, Y., Sumida, H., Matsui, K., Jinnouchi, H., & Ogawa, H. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.022 · Cited by 293
Schnabel, R. B., Larson, M. G., Yamamoto, J. F., Sullivan, L. M., Pencina, M. J., Meigs, J. B., Tofler, G. H., Selhub, J., Jacques, P. F., Wolf, P. A., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.882241 · Cited by 293
Self-citationXanthakis, V., Enserro, D. M., Murabito, J. M., Polak, J. F., Wollert, K. C., Januzzi, J. L., Wang, T. J., Tofler, G., & Vasan, R. S. (2014) · Circulation · doi:10.1161/circulationaha.114.009273 · Cited by 287
Self-citationWare, L. B., Koyama, T., Billheimer, D. D., Wu, W., Bernard, G. R., Thompson, B. T., Brower, R. G., Standiford, T. J., Martin, T. R., & Matthay, M. A. (2010) · Chest · doi:10.1378/chest.09-1484 · Cited by 285
Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies
Grandi, N. C., Breitling, L. P., & Brenner, H. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.06.013 · Cited by 280
Prognostic and predictive factors in colorectal cancer
Zlobec, I., & Lugli, A. (2008) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.054858 · Cited by 280
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
(2010) · National Academies Press eBooks · doi:10.17226/12869 · Cited by 276
Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
Tzoulaki, I. (2009) · JAMA · doi:10.1001/jama.2009.1757 · Cited by 276
The role of HIV in serious diseases other than AIDS.
Phillips, A. N., Neaton, J., & Lundgren, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283174636 · Cited by 269
“Results for interleukin-6, a cytokine linked to the acute phase response, and D-dimer, a coagulation marker known to predict CVD and all-cause mortality in the general population [69], were particularly interesting.”
Protein Biomarkers of Cardiovascular Disease and Mortality in the Community
Ho, J. E., Lyass, A., Courchesne, P., Chen, G., Liu, C., Yin, X., Hwang, S., Massaro, J. M., Larson, M. G., & Levy, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008108 · Cited by 269
Self-citationCopeptin: A novel, independent prognostic marker in patients with ischemic stroke
Katan, M., Fluri, F., Morgenthaler, N. G., Schuetz, P., Zweifel, C., Bingisser, R., Müller, K., Meckel, S., Gass, A., Kappos, L., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21783 · Cited by 267
Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study
O’Donnell, C. J., & Elosua, R. (2008) · Revista Española de Cardiología · doi:10.1157/13116658 · Cited by 266
Biological Markers of Acute Kidney Injury
Siew, E. D., Ware, L. B., & Ikizler, T. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080796 · Cited by 266
Cardiovascular Risk Factors. Insights From Framingham Heart Study
O'Donnell, C. J., & Elosua, R. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60118-8 · Cited by 265
The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome
Nilsson, P. M., Lurbe, E., & Laurent, S. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f82c3e · Cited by 261
Kones, R. (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 259
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Jin, Q., & Ma, R. C. W. (2021) · Cells · doi:10.3390/cells10112832 · Cited by 252
Quantifying importance of major risk factors for coronary heart disease
Pencina, M. J., Navar, A. M., Wojdyla, D., Sanchez, R. J., Khan, I., Elassal, J., D’Agostino, R. B., Peterson, E. D., & Sniderman, A. D. (2019) · Circulation · doi:10.1161/circulationaha.117.031855 · Cited by 247
Self-citationNishimura, K., Okamura, T., Watanabe, M., Nakai, M., Takegami, M., Higashiyama, A., Kokubo, Y., Okayama, A., & Miyamoto, Y. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19356 · Cited by 228
Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222
Self-citationKohler, C., Radpour, R., Barekati, Z., Asadollahi, R., Bitzer, J., Wight, E., Bürki, N., Diesch, C., Holzgreve, W., & Zhong, X. Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-105 · Cited by 215
Cardiovascular risk assessment scores for people with diabetes: a systematic review
Chamnan, P., Simmons, R. K., Sharp, S. J., Griffin, S. J., & Wareham, N. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1454-0 · Cited by 176
“Few novel biomarkers have demonstrated an ability to predict risk over and above information available from global assessment tools such as Framingham [38, 41 ].”
BackgroundSystematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.
Ip, S., Lichtenstein, A. H., Chung, M., Lau, J., & Balk, E. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-7-200904070-00007 · Cited by 163
“No data (1) CVD or CVD death (1) Intracerebral hemorrhage (1) Particle number nmol/L (10), higher level 8806 (260–3066) CAD or CAD death (4) Good (2) 7/9 Higher concentration 4 (or 5)/5 (or 6) 3/4 Higher concentration CVD or CVD death (3) Fair (8)”
BackgroundNovel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
Sattar, N., Wannamethee, S. G., & Forouhi, N. G. (2008) · Diabetologia · doi:10.1007/s00125-008-0954-7 · Cited by 143
Ferket, B. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.434 · Cited by 134
Mora, S., Caulfield, M. P., Wohlgemuth, J., Chen, Z., Superko, H. R., Rowland, C. M., Glynn, R. J., Ridker, P. M., & Krauss, R. M. (2015) · Circulation · doi:10.1161/circulationaha.115.016857 · Cited by 126
How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators
Cooney, M. T., Dudina, A., De Bacquer, D., Fitzgerald, A., Conroy, R., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., et al. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283213140 · Cited by 121
Tomiyama, H., Matsumoto, C., Shiina, K., & Yamashina, A. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.32979 · Cited by 109
Li, M., Duan, L., Cai, Y.-L., Li, H.-Y., Hao, B.-C., Chen, J.-Q., & Liu, H.-B. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01092-7 · Cited by 71
Associations between Eating Competence and Cardiovascular Disease Biomarkers
Psota, T. L., Lohse, B., & West, S. G. (2007) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2007.05.004 · Cited by 67
Tomaschitz, A., Pilz, S., Ritz, E., Morganti, A., Grammer, T., Amrein, K., Boehm, B. O., & Marz, W. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr150 · Cited by 64
Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps
Isserlin, R., Merico, D., Alikhani‐Koupaei, R., Gramolini, A., Bader, G. D., & Emili, A. (2010) · PROTEOMICS · doi:10.1002/pmic.200900412 · Cited by 63
Zukotynski, K., Jadvar, H., Capala, J., & Fahey, F. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s31804 · Cited by 51
Metadata
- Authors
- Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., Benjamin, E. J., D'Agostino, R. B., & Vasan, R. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-12-21
- Volume
- 355
- Issue
- 25
- Pages
- 2631-2639
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2133685977
- Cited by
- 1,343
- References
- 40
- FWCI
- 112.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.